News

Although collectively dermatologists are doing more, each dermatologist may be doing less in the higher quintiles.

Some authors of AAD clinical practice guidelines received sizable payments from industry that were not completely disclosed, JAMA Dermatology Reports.

Humor may be subjective, but carefully and respectfully adding it to the practice can help create a positive environment for both doctor and patient.

Now that we have flipped the calendar to a new year, it’s time to say good-bye to some things we all lost in 2017.

Big cash offers not always best for the practice or patient.

A rising prevalence of skin disorders, including melanoma, will drive the need for diagnostic imaging and treatment technologies in dermatology, market analysts say.

The January issue of Dermatology Times focuses on the role of technology in clinical practice beginning with artificial intelligence for skin cancer detection and device trends in 2018. (©Elnur/Shutterstock.com)

Dermatologists should be prepared to counsel patients about PBMT home-based treatment options for hair loss, say dermatologists from the University of Minnesota who reviewed 13 FDA-approved PBMT devices. (©EvgeniyKalinovskiy/Shutterstock.com)

A conversation with ASDS president-elect Murad Alam, M.D.

Dermatologists will need to understand new device technologies and incorporate them judiciously into disease treatment where appropriate.

The FDA has proposed regulating the cosmetic industry, says Dr. Zoe Diana Draelos in her monthly Dermatology Times column, "Cosmetic Conundrums." This month Dr. Draelos examines three key questions about cosmetic safety.

Soap has probably done more to improve world health than any prescription medication, says Dr. Zoe Diana Draelos in her monthly Dermatology Times column, "Cosmetic Conundrums."

In 2018 at just five days into the New Year, a search of PubMed revealed 86 new psoriasis studies. So, who is leading the pack?

Study shows no significant difference in herpes zoster risk between psoriasis patients receiving systemic therapy and those not receiving systemic therapy.

Dr. Derm logged into his office computer system, only to find a ransom note from a hacker, asking for money in exchange for the safe return of his patients’ records. Who are these hackers? How do they gain access? What should Dr. Derm do?

Although most malpractice cases against dermatologists are abandoned, withdrawn or dismissed, communication with patients may minimize liability.

Neural networks do pattern recognition just as a dermatologist would learn patterns and visual data. Computer accuracy rivals that of humans for classifying skin cancer. Deep neural networks and artificial intelligence may have a growing role in practice.

The cost of doxycycline hyclate prescriptions increased 1,854% between 2011 and 2013 in a retrospective analysis of commercial claims data, and there was no association between market concentration and price of the oral antibiotic. Clinician or pharmacy level interventions to choose less costly oral tetracycline-class antibiotics could result in substantial cost savings.

Dermatologists need to be aware of margin of error and related issues that can affect the results of biosimilar clinical trials, a study shows.

What exciting new devices, drugs and treatments will the New Year bring dermatologists and their patients? Physicians in the specialty and others share what they most anticipate in the coming year.

The dermatology community experienced big strides in medical and cosmetic dermatology in 2017. Dermatologists share what they think were major breakthroughs throughout the year.

In this installment of our melanoma case studies series, we focus on common cancers in unusual locations versus uncommon cancers in classic locations.

The holidays can be stressful, but rest assured, you can get through them with peace and joy instead of tension and oy vey. It just takes some mindfulness.

Weren’t we all preparing for the holidays in 2016 about a week ago? Time flies when you’re helping patients. To that end, we asked dermatologists to reflect on 2017, and summarize it using just one word (or two) with a brief explanation.

With the internet being available at everyone's fingertips and seemingly endless advertising for a variety of skincare and cosmetic products, the average patient may come to an appointment with misinformation and questions.

Thinking of psoriasis and atopic dermatitis as a spectrum, rather than separate diseases might lead to better understanding, and potentially better treatments.

A retrospective study shows that early propranolol-induced heart rate reductions fail to predict clinical response of infantile hemangiomas.

Ocular comorbidity risk is already high in patients with atopic dermatitis and may increase even further as biologic agents are introduced, a study shows.

ISSVA clinical classifications aren't enough to accurately identify vascular malformation subtypes, according to a recent review.